Overview

Study to Assess Pharmacokinetics, Pharmacodynamics and Safety of Tiprogrel in Healthy Subjects

Status:
COMPLETED
Trial end date:
2024-12-17
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the pharmacokinetics, pharmacodynamics and safety in healthy subjects with multiple administration of Tiprogrel.
Phase:
PHASE1
Details
Lead Sponsor:
Tianjin Institute of Pharmaceutical Research Co., Ltd
Treatments:
Clopidogrel
Ticagrelor